The paper was recognized by the Society of Toxicology’s Medical Device and Combination Product Specialty Section.

Proteomics revealed molecular mechanisms by which the drug Verapamil could prolong beta cell function in early-onset type 1 diabetes patients.

Study highlights microbiome’s role in regulating xenobiotic metabolism.

Recognizing how innovation and clean technologies at the very edge of the grid can work together to transition the electricity system, PNNL takes a multidisciplinary approach to advancing and integrating renewable energy solutions.

Development of a one-meter path length miniature ion mobility spectrometer based on multilevel structures for lossless ion manipulations.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

The eighth Arab-American Frontiers of Science, Engineering, and Medicine Symposium, co-organized by PNNL engineer and research line manager Leonard Pease, brought together multi-disciplinary researchers from around the globe.

Studying MERS-CoV may lead to better treatments for a host of respiratory illnesses, including the many variants of COVID-19.

A study raises questions about how far droplets, like those that carry the virus that causes COVID-19, can travel before becoming harmless.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.

Simulations reveal advantages of using new model vs. allometric scaling for risk assessment.

From water purification, to better batteries and tools to foil a cyberattack—a look back at how PNNL helped to invent a brighter and better future over the last year.

A multi-institutional team has obtained information about nanoscale interactions between the spike protein of the novel coronavirus SARS-CoV-2 and common household inorganic surfaces.

Researchers map nearly 9,000 proteins in the human lungs, providing a clearer picture of development.

Customized molecular tools identify specific microbial functions that are key to healthy people and environments.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

PNNL has received 119 R&D 100 Awards since 1969, when the laboratory began submitting entries in the contest that recognizes top 100 inventions each year.

PNNL has paired one of its offshore wind research buoys with its ThermalTracker-3D technology to correlate avian activity with ocean and weather conditions off the California coast.

Exposure to polycyclic aromatic hydrocarbons found at Superfund Sites induces enzymes in dose- and time-dependent patterns in mice.